Elisabet Rodriguez Llorian
Overview
Explore the profile of Elisabet Rodriguez Llorian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Greenfield J, Metz L, Khakban A, Llorian E, Michaux K, Traboulsee A, et al.
Mult Scler Relat Disord
. 2023 Nov;
80:105091.
PMID: 37924714
Background: Long-term population-based safety studies are needed to investigate cancer outcomes in people with multiple sclerosis (MS) treated with modern disease-modifying therapy (DMT). Objectives: To investigate if exposure to DMT...
2.
Borle K, Kopac N, Dragojlovic N, Llorian E, Lynd L
Clin Ther
. 2023 Jul;
45(8):695-701.
PMID: 37516568
Rapid growth in the volume of referrals to clinical genetics services in many countries during the past 15 years makes workforce planning a critical policy tool in ensuring that the...
3.
Llorian E, Zhang W, Khakban A, Michaux K, Patten S, Traboulsee A, et al.
Mult Scler
. 2023 Apr;
29(7):866-874.
PMID: 37060245
Background: Multiple Sclerosis (MS) affects people in their most productive years of life. Consequently, MS can substantially affect employment and work-related outcomes. Objectives: This study characterizes productivity loss and employment...
4.
Llorian E, Waliji L, Dragojlovic N, Michaux K, Nagase F, Lynd L
Value Health
. 2023 Mar;
26(8):1258-1269.
PMID: 36990207
Objectives: Early health technology assessment (eHTA) can be used to evaluate and optimize a medical product's value proposition and to inform go/no-go decisions by using health economic modeling, literature scanning,...
5.
Llorian E, Kopac N, Waliji L, Borle K, Dragojlovic N, Elliott A, et al.
Value Health
. 2023 Mar;
26(9):1286-1295.
PMID: 36921900
Objectives: Increasing access to health data through biobanks containing genetic information has the potential to expand the knowledge base and thereby improve screening, diagnosis, and treatment options for many diseases....
6.
Khakban A, Llorian E, Michaux K, Patten S, Traboulsee A, Oh J, et al.
Neurology
. 2022 Nov;
100(9):e899-e910.
PMID: 36450607
Background And Objectives: Multiple sclerosis (MS), a leading cause of nontraumatic neurologic disability in young adults, exerts a substantial economic burden on the health care system. The objective of this...
7.
Llorian E, Dragojlovic N, Campbell T, Friedman J, Osiovich H, Elliott A, et al.
Genet Med
. 2022 May;
24(8):1675-1683.
PMID: 35622065
Purpose: This study aimed to compare downstream utilization of medical services among critically ill infants admitted to intensive care units who received rapid exome sequencing (ES) and those who followed...
8.
Llorian E, Zhang W, Khakban A, Patten S, Traboulsee A, Oh J, et al.
Mult Scler
. 2022 Feb;
28(9):1414-1423.
PMID: 35137613
Objectives: To analyze work productivity loss and costs, including absenteeism (time missed from work), presenteeism (reduced productivity while working), and unpaid work loss, among a sample of employed people with...
9.
Borle K, Kopac N, Dragojlovic N, Llorian E, Friedman J, Elliott A, et al.
Eur J Hum Genet
. 2022 Jan;
30(5):496-504.
PMID: 35031678
Driven by technological and scientific advances, the landscape of genetic medicine is rapidly changing, which complicates strategic planning and decision-making in this area. To address this uncertainty, we sought to...
10.
Llorian E, Mason G
Health Econ
. 2021 Mar;
30(5):1124-1138.
PMID: 33751736
Improvements in quality of care through supporting decision-making processes and increased efficiency have prompted widespread implementation of electronic medical records (EMRs) in Canada. Using a set of indicators of preventive...